Virtue® SAB in the Treatment of Coronary ISR Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 740 participants.
Also called NCT07045194
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 740 participants
- Sponsor
- Orchestra BioMed, Inc
- Registry
-
NCT07045194
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07045194. Randomized; single masking; primary purpose treatment. Start 2025-10-20 (actual); primary completion 2028-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Virtue® SAB in the Treatment of Coronary ISR Trial
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Virtue Sirolimus AngioInfusion Balloon
- Intervention (Device)
- AGENT™ Paclitaxel Drug-Coated Balloon
- Lead sponsor
- Orchestra BioMed, Inc
Record details
- Record id
cardio:ct-nct07045194- Content hash
332b01a1fb1198ed5e191a634ea8a09e0756410c86cd8c6dd3ce7bfb4df56b7c